Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

36°
- Poteau, OK (74953)
  Today
  
  Sunny. High around 40F. Winds NW at 10 to 20 mph..
  
  Tonight
  
  Mainly clear skies. Near record low temperatures. Low 24F. WNW winds shifting to SSW at 10 to 15 mph.
  
  Updated: March 16, 2026 @ 2:21 pm
- Full Forecast

Site search

Home
News
Sports
Obituaries
Photos
PDN E-Edition
Classifieds
- Place an ad
Antlers American E-Edition
Archives
Best of 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

57.25 -1.26 (-2.15%)

Streaming Delayed Price Updated: 3:54 PM EDT, Mar 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioMarin Pharmaceutical Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

NASDAQ:BMRN is not too expensive for the growth it is showing. ↗

May 21, 2024

Looking for growth without the hefty price tag? Consider BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN).

Via Chartmill

Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024) ↗

May 19, 2024

Last week, these 10 large-cap stocks had the worst performance. NICE, PBR, FIX, LI, MLM, VMC, BMRN, EDU, GFI, MUFG all saw significant decreases.

Via Benzinga

4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market ↗

May 18, 2024

Plain-as-day bargains can still be found, even with the innovation-fueled Nasdaq Composite powering to a fresh all-time high.

Via The Motley Fool

Topics Stocks

Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday ↗

May 17, 2024

Via Benzinga

Analyst Ratings For Biomarin Pharmaceutical ↗

May 14, 2024

Via Benzinga

(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest ↗

May 09, 2024

Via Benzinga

Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings) ↗

April 25, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 15, 2024

Via Benzinga

The 3 Best Biotech Stocks to Buy in May 2024 ↗

May 09, 2024

If you have the appetite for the risk inherent in the biotech sector, here are three biotech stocks to buy in May.

Via InvestorPlace

Citi Just Cut Its Price Target on These 3 Stocks ↗

May 03, 2024

Reviewing analyst downgrades may help safeguard investment portfolios amid market uncertainty and Citi price target cuts.

Via InvestorPlace

For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering. ↗

April 30, 2024

For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.

Via Chartmill

4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market ↗

April 27, 2024

Opportunistic investors can still find bargains, even with the Nasdaq Composite up 49% since the start of 2023.

Via The Motley Fool

Topics Stocks

Looking Into Biomarin Pharmaceutical's Recent Short Interest ↗

April 03, 2024

Via Benzinga

The Latest Analyst Ratings For Biomarin Pharmaceutical ↗

February 23, 2024

Via Benzinga

Recap: Biomarin Pharmaceutical Q4 Earnings ↗

February 22, 2024

Via Benzinga

Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 25, 2024

Via Benzinga

3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition ↗

April 25, 2024

Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now.

Via InvestorPlace

BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Misses Revenue for Q1 2024 ↗

April 24, 2024

BMRN stock results show that Biomarin Pharmaceutical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Decoding 8 Analyst Evaluations For Biomarin Pharmaceutical ↗

January 30, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical ↗

December 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 24, 2024

Via Benzinga

Don't overlook NASDAQ:BMRN—a stock with solid growth prospects and a reasonable valuation. ↗

April 08, 2024

Investors seeking growth at a reasonable cost should explore BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN).

Via Chartmill

While growth is established for NASDAQ:BMRN, the stock's valuation remains reasonable. ↗

March 18, 2024

Despite its growth, BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) remains within the realm of affordability.

Via Chartmill

4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market ↗

March 16, 2024

Although the Nasdaq Composite is galloping to record highs, amazing deals among growth stocks can still be uncovered.

Via The Motley Fool

Topics Stocks

Investors seeking growth at a reasonable cost should explore NASDAQ:BMRN. ↗

February 26, 2024

For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.

Via Chartmill

7 Biotech Stocks Fighting America’s Deadliest Diseases ↗

February 08, 2024

Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship.

Via InvestorPlace

3 No-Brainer Stocks to Buy With $200 Right Now ↗

February 07, 2024

A reasonably small amount of money can go a long way when it's put to work in innovative, industry-leading businesses.

Via The Motley Fool

4 Marvelous Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip ↗

January 20, 2024

A greater than 7% decline in the Nasdaq Composite from its record high signals that opportunistic investors can still find bargains.

Via The Motley Fool

Topics Stocks

If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names ↗

January 10, 2024

Biotech is one of the areas of interest in the market today, adding a biotech stock could be huge play this month.

Via InvestorPlace

4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip ↗

December 02, 2023

An 11% decline in the Nasdaq Composite over the past two years is an open invitation for opportunistic growth investors to go shopping.

Via The Motley Fool

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Poteau Daily News

PoteauDailyNews.com
804 N. Broadway
Poteau, OK 74953
Phone: 918-647-3188
Email: circulation@poteaudailynews.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Poteau, OK (74953)

Today

Tonight

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

All News about BioMarin Pharmaceutical Inc. - Common Stock

Sections

Services

Poteau Daily News